Marc Bonten appointed as new top scientist at RIVM On 1 July, Prof. Dr Marc Bonten, Clinical Microbiologist, took office as a top academic staff member at the RIVM Centre for Infectious Disease Control.
National Heat Plan active The National Heat Plan became active in the Netherlands on June 30th. This means that it is necessary to take preventive health measures for vulnerable groups.
Standards for three drugs in Dutch surface water RIVM proposes water quality standards for three drugs in surface water: carbamazepine (epilepsy), metoprolol (heart disease) and metformin (diabetes).
Safety of the nanomaterial SAS (silica) in food still uncertain Uncertainty still remains over the safety of the nanomaterial SAS in food. Food additive E551 consists of ‘synthetic amorphous silica’ (SAS) and is applied as an anti-caking agent.
Open and sustainable building for RIVM and MEB The Central Government Real Estate Agency has awarded the contract to build new premises for two knowledge institutes - RIVM and the MEB - to StruktonHurks.
No new MERS patients in the Netherlands Almost two months ago, two Dutch people were diagnosed with the MERS coronavirus.
Declaration PAN Europe regarding RIVM Statement of PAN Europe regarding the contents of her report ‘A Poisonous Injection’ June 26, 2014.
Average participation in the National Immunisation Programme in the Netherlands around 95% From the RIVM report 'Vaccination level of the National Immunisation Programme of the Netherlands' (report year 2014) the strong commitment of Community Health Services (GGD’s) and child welfare ce
Examine patients with acute Q fever again after a year If patients with acute Q fever are re-examined for antibodies one year after their infection, 98% of the patients with chronic Q fever can be detected.